How would you manage a patient with low-volume non-invasive endometrioid carcinoma that is found in both the endometrium and ovary (pN0)?
Would you approach this situation as synchronous primaries (eg. FIGO IA in both) or as a locally advanced endometrial cancer (FIGO IIIA)?
What adjuvant therapy would you recommend?
Answer from: Radiation Oncologist at Community Practice
Isolated ovarian involvement in endometrial cancer is uncommon, and previous data from the Gynecologic Oncology Group and other single-institution series suggest that it occurs in less than 5% of patients. (Creasman et al. Cancer, 1987; Lin et al. Gynecol Oncol, 2015) Adnexal involvement when presen...
Answer from: Radiation Oncologist at Community Practice
The data suggest most of these patients in absence of adverse factors are/behave like synchronous two primary rather than metastatic disease Sometimes LOH analysis can also help distinguish metastatses vs. two primary. Our approach in absence of adverse factor (deep myometrial involvement...